Welcome to Fulton medicinali S.p.A.
Fulton medicinali S.p.A. is a full Italian capital company, founded in 1985. Its "core business" resides in the research, development, formulation, production and pharmaceutical packaging of products to Fulton brand and for third parties. Fulton medicinali is authorized for the production of different pharmaceutical forms including tablets (oral and vaginal), hard gelatin capsules, suppositories, ovules, cutaneous powders and dry syrups for extemporaneous preparation. Fulton medicinali is a dynamic, demonstrating continuous evolution and growth based on reliability, competence and the high quality level of services and manufactured products.
On June 05, 2019 the Swiss pharmaceutical company PHF SA, joining the Italian NineTrees Group, formerly owned by F.I.S., acquired Fulton Medicinali spa.
Nine Trees Group SpA is an important group that operates in the production of products and services for the global pharmaceutical industry and is present in Italy and abroad with several companies: F.I.S. – Fabbrica Italiana Sintetici S.p.A. (IT), Delmar (CA), FIS North America (USA), PHF SA (CH), China Office (PRC), Anemocyte (IT) and Brenta (IT).
This acquisition allows PHF SA to expand its range of products and services and Fulton Medicinali spa to integrate into an international group.
As to whether relationships will continue with the utmost trust and collaboration, while maintaining high standards of quality and safety, we remain available for further clarification.